Navigation Links
Bladder Cancer No Longer a Death Sentence
Date:6/30/2009

SARASOTA, Fla., June 30 /PRNewswire/ -- At 51, Charles Daniels had a lot to live for. A thriving construction business, a precious 11 year old daughter and a happy long-term relationship. When he was diagnosed with bladder cancer, he was determined to beat the odds. According to TMD, a medical tourism corporation, Daniels case is typical - he tried conventional medicine until they had nothing left to offer but a poor prognosis, and then went out of the country for alternative cancer treatment and is cancer free today.

Just before Christmas 2007, Daniels urinated blood. He went right to his primary care doctor, who did an ultrasound and X-rays, which were inconclusive. Suspecting an infection, his doctor gave him antibiotics. Within 24 hours, the blood was no longer visible. But a follow up visit showed microscopic blood in his urine, and he was sent to a urologist. A cytoscopy exam (where a small camera is inserted into the bladder) and intra-venous pyelogram (an X-ray with contrast that provides pictures of the entire urinary system) found bladder cancer. "I was shocked," Daniels said. "I was in perfect health, I felt good, and I thought I just had an infection."

This year, almost 71,000 Americans will be diagnosed with bladder cancer. According to the National Cancer Institute, the survival rate for stage III bladder cancer is 50%; stage IV is rarely survived. Symptoms include blood in the urine and frequent, painful or urgent urination.

Risk factors are smoking, chemical exposure to dyes, rubber and pesticides, chronic infections and parasites. Women undergoing chemotherapy and radiation for cervical cancer also have an increased risk of developing bladder cancer.

Daniels' oncologist recommended surgery to remove the tumor. While his doctor was cautiously optimistic, further testing confirmed the invasive tumor had penetrated the muscle wall. "My doctor wanted to remove my bladder, prostate and surrounding lymph nodes, and create a new bladder from my intestines. He said with this surgery I had a 90% survival rate. I wanted to live, and 90% sounded like a good number."

Daniels expected to wake up after surgery and be cancer free. But his surgeon found that the tumor had grown outside the bladder wall and surrounding lymph nodes tested positive. His survival rate dropped from 90% to 40%. Despite an aggressive chemotherapy program, his next CAT scan revealed three new tumors in his liver. He now was stage IV. At this point, mainstream medicine offered no hope of cure, and his life expectancy dropped to around nine months. The chemotherapy left him feeling exhausted and sick, and he suffered weight and hair loss. Permanent side effects included hearing loss, tingling in his extremities and 'chemo brain'.

Next, Daniels underwent Radio Frequency Ablation (RAF), a guided imagery surgery where a needle like probe transmits microwaves into tumors causing the destruction of tumor cells. The RAF destroyed the tumors, but he was told they would come back - there is no mainstream cure for his cancer.

Daniels then began researching alternative treatments. He sent emails with his medical history to clinics throughout the United States and Mexico. He interviewed doctors and talked to patients. When he asked about success rates, the answers he received ranged from "we'll make you more comfortable" to "complete remission".

Finally, he learned about a fairly new cancer treatment called SonoPhoto Dynamic Therapy (SPDT). This non-invasive treatment uses a non-toxic sensitizing agent along with sound and light to destroy cancer cells. Dr. Antonio Jimenez, medical director of the Hope4Cancer Institute south of San Diego, California in Baja, Mexico, has successfully treated bladder and other cancers with this program. Although this is a natural treatment without side effects, SPDT is considered a mainstream cancer treatment in 25 European countries. SPDT has proven effective against ovarian, prostate, colon, lung, pancreatic, liver and breast cancers, among others. It has not yet been approved in the United States.

Daniels decided to travel to Mexico for two weeks of SPDT treatment followed by a two month home program. "My doctors were not opposed to this," Daniels says. "They had nothing left to offer me."

"From the minute I walked into this clinic I had hope." Daniels says the doctors were upbeat and the staff was exceptionally caring. "The treatment was painless and there were no side effects. When I finished the program, my CAT scans were absolutely clear and my blood work was normal. I continue to have testing done every few months, and I am still completely cancer free. I stay on a maintenance program. I am going to watch my daughter grow up. I married my long time sweetheart. I only wish I would have found this treatment sooner."

Marla Manhart is a health writer and patient advocate. She can be reached at: mkmsrq@gmail.com


'/>"/>
SOURCE TMD Limited Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen
2. Botox injections can significantly improve quality of life for people with overactive bladders
3. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
4. Study Cites Gains in Gall Bladder Cancer Treatment
5. Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
6. New Data Presented at AUAs Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients
7. Mayo Clinic researcher says improved detection of bladder tumors reduces cancer recurrence
8. Genetic analysis may predict risk of invasive bladder cancer
9. Genetic variants predict recurrence of bladder cancer, patient survival
10. Know Your Bladder Better
11. More intensive treatment not associated with better outcomes in early bladder cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman ... Van Allen have signed a joint enrollment and degree completion agreement. The ... associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students to ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , ... Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated ... hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We ...
(Date:2/5/2016)... ... 05, 2016 , ... Regular gym users know the routine: each January, they ... access the treadmills. It’s a predictable trend. After the excesses of November and December, ... shape by joining gyms, starting new walking or running routines, or signing up for ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... in the 2015 Best in KLAS: Software & Services for HIT Implementation Support ... in KLAS report independently ranks vendor performance by healthcare executives, managers and clinicians ...
(Date:2/5/2016)... WORCESTER, MA (PRWEB) , ... February 05, 2016 , ... ... latest in tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal ... cutting-edge option with unmatched results. , Developed by Cynosure, the PicoSure has been approved ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:2/4/2016)... 2016  Omnicell, Inc. (NASDAQ: OMCL ), a leading ... systems, today announced results for its fiscal year and ... --> GAAP results: Revenue for the ... million or 4.1% from the third quarter of 2015, ... quarter of 2014. Revenue for the year ended December 31, ...
Breaking Medicine Technology: